Ganesh Yadagiri

About

Development of nanomedicines and nanovaccines for infectious diseases especially for Visceral leishmaniasis, Influenza, Salmonella and SARS CoV-2. Studying mucosal immunity and development of novel immunotherpies for infectious diseases.

Employment

• National Institute of Pharmaceutical Education and Research Assistant Professor
  2025 - Present
• The Ohio State University Wexner Medical Center Post Doctoral Researcher
  2024 - 2025
• The Ohio State University Post Doctoral Researcher
  2022 - 2024
• College of Food, Agricultural, and Environmental Sciences, Ohio State University Visiting Scholar
  2021 - 2022
• Institute of Nano Science and Technology Research Fellow
  2019 - 2021
• Jawaharlal Nehru Technological University Kakinada Assistant Professor (Guest Faculty)
  2019 - 2020

Education

• Andhra University B.Pharmacy
  2008 - 2012

Projects & Funding

Projects & funding information is unavailable.

Publications (29)

• 3-Nitropropionic Acid–Induced Huntington’s Disease in Preclinical Models: Mechanisms, Peripheral Toxicities, Model Gaps, and Future Directions
  Molecular Neurobiology 2026 DOI: 10.1007/s12035-026-05967-w
  +Save
• Vaccine Development for Influenza Virus
  Vaccines 2025 DOI: 10.3390/vaccines13101068
  +Save
• Influenza Virus: Global Health Impact, Strategies, Challenges, Role of Nanotechnolgy in Influenza Vaccine Development
  Vaccines 2025 DOI: 10.3390/vaccines13090890
  +Save
• Cancer-Associated Fibroblasts: Immunosuppressive Crosstalk with Tumor-Infiltrating Immune Cells and Implications for Therapeutic Resistance
  Cancers 2025 DOI: 10.3390/cancers17152484
  +Save
• HO-3867 mediated modulation of Extracellular vesicles and Tumor microenvironment: A novel immunotherapeutic strategy for ovarian cancer
  2025 DOI: 10.1101/2025.05.16.653814
  +Save
• Unveiling the Multifaceted Pharmacological Actions of Indole-3-Carbinol and Diindolylmethane: A Comprehensive Review
  Plants 2025 DOI: 10.3390/plants14050827
  +Save
• Advanced Biomaterials in Neuroprotection: Innovations and Clinical Applications
  Biomaterials and Neurodegenerative Disorders 2025 DOI: 10.1007/978-981-97-9959-6_4
  +Save
• Human Infant Fecal Microbiota Differentially Influences the Mucosal Immune Pathways Upon Influenza Infection in a Humanized Gnotobiotic Pig Model
  Current Microbiology 2024 DOI: 10.1007/s00284-024-03785-8
  +Save
• Characterization of a novel functional porcine CD3+CD4lowCD8α+CD8β+ T-helper/memory lymphocyte subset in the respiratory tract lymphoid tissues of swine influenza A virus vaccinated pigs
  Veterinary Immunology and Immunopathology 2024 DOI: 10.1016/j.vetimm.2024.110785
  +Save
• Evaluation of Efficacy of Surface Coated versus Encapsulated Influenza Antigens in Mannose–Chitosan Nanoparticle-Based Intranasal Vaccine in Swine
  Vaccines 2024 DOI: 10.3390/vaccines12060647
  +Save